tiprankstipranks
Trending News
More News >
Zelira Therapeutics (ZLDAF)
OTHER OTC:ZLDAF
Advertisement

Zelira Therapeutics (ZLDAF) Revenue

Compare
16 Followers

Zelira Therapeutics Revenue

Zelira Therapeutics had a revenue of 0.00 in the quarter ending Jun 30, 2025, with -100.00%. This bring the company's revenue in the last twelve months to 655.00, Increased -98.40%. In the fiscal year ending Dec 31, 2025, Zelira Therapeutics had annual revenue of 656.00 with -99.31% growth.
Revenue (ttm)
655.00
Revenue Growth
P/S Ratio
4526.23
Revenue/Employee
$82
Employees
8
Market Cap
$2.97M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
656.00-94.30K+0.69%
Dec 31, 2024
94.95K-206.17K+31.53%
Dec 31, 2023
301.12K-1.24M+19.55%
Dec 31, 2022
1.54M877.31K+232.26%
Dec 31, 2021
663.32K-66,331,600.00%
Dec 31, 2020
-769.03K
Dec 31, 2019
769.03K455.27K+245.10%
Dec 31, 2018
313.76K213.72K+313.63%
Dec 31, 2017
100.04K-199.96K+33.35%
Dec 31, 2016
300.00K
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis